Capricor Therapeutics Inc (CAPR) R&D Expenses & History | Stock Alarm

Capricor Therapeutics Inc · R&D Expenses

CAPR R&D Expenses

Latest reported$99.73Mperiod endingJun 30, 2026

CAPR R&D Expenses ($0.00 → $99.73M)

Annual R&D Expenses

High-resolution chart · PNG

CAPR r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Capricor Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	84,454,595
Dec 31, 2024	49,968,585
Dec 31, 2023	36,448,039
Dec 31, 2022	21,816,949
Dec 31, 2021	13,571,045
Dec 31, 2020	8,457,000
Dec 31, 2019	5,141,805
Dec 31, 2018	12,067,000
Dec 31, 2017	10,766,000
Dec 31, 2016	16,042,000
Dec 31, 2015	13,757,000
Dec 31, 2014	7,787,000
Dec 31, 2013	5,197,000
Dec 31, 2012	1,024,000
Dec 31, 2011	4,137,000
Dec 31, 2010	4,081,000
Dec 31, 2009	4,467,000
Dec 31, 2008	9,478,000
Dec 31, 2007	5,124,000
Dec 31, 2006	2,700,056
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.